News

• BioNTech starts clinical trial of malaria vaccine
  12/23/2022 / 11:46 - TeleTrader
•  
• Sanofi, GSK surge as court dismisses Zantac suits
  12/07/2022 / 11:52 - TeleTrader
•  
• EU approves Sanofi-GSK booster COVID jab
  11/10/2022 / 17:51 - TeleTrader
•  
• GSK's Q3 turnover jumps 18% to £7.8 billion
  11/02/2022 / 08:06 - TeleTrader
•  
• GSK appoints Burberry's Brown as CFO, Mackay retires
  09/26/2022 / 08:24 - TeleTrader
•  
• GSK falls 12% on worries over Zantac litigation
  08/11/2022 / 14:06 - TeleTrader
•  
• GSK spinoff Haleon starts trading in London
  07/18/2022 / 11:01 - TeleTrader
•  
• Sanofi: COVID shot has 72% Omicron efficacy
  06/24/2022 / 09:44 - TeleTrader
•  
• US FDA approves GSK's Priorix vaccine
  06/06/2022 / 09:43 - TeleTrader
•  
• GSK to acquire Affinivax in $3.3 billion deal
  05/31/2022 / 08:36 - TeleTrader
•  
• GSK's turnover at £9.78B in Q1, up 32% YoY
  04/27/2022 / 08:10 - TeleTrader
•  
• EMA begins reviewing Sanofi-GSK COVID-19 vaccine
  03/30/2022 / 17:37 - TeleTrader
•  
• US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
  03/25/2022 / 21:04 - GlobeNewswire
•  
• Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
  03/21/2022 / 01:00 - GlobeNewswire
•  
• Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
  03/17/2022 / 12:08 - GlobeNewswire